Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.6B |
| 2 |
American Express
AXP
|
+$398M |
| 3 |
Capital One
COF
|
+$151M |
| 4 |
Apollo Global Management
APO
|
+$111M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$109M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
Amazon
AMZN
|
+$403M |
| 4 |
NVIDIA
NVDA
|
+$356M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$283M |
Sector Composition
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.22% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Custom Truck One Source
CTOS
$1.29B
| $902K | ﹤0.01% |
+133,900
| New | +$902K |
|
2352
Capital City Bank Group
CCBG
$737M
| $898K | ﹤0.01% |
29,300
| – | – |
|
|
TGB
2353
Taseko Mines
TGB
$1.08B
| $896K | ﹤0.01% |
623,700
| – | – |
|
2354
First Community Bankshares
FCBC
$684M
| $894K | ﹤0.01% |
30,079
-1,400
| -4% | -$41.6K |
|
|
CRON
2355
Cronos Group
CRON
$969M
| $894K | ﹤0.01% |
453,100
| – | – |
|
|
EQRX
2356
DELISTED
EQRx, Inc. Common Stock
EQRX
| $890K | ﹤0.01% |
478,700
+162,500
| +51% | +$302K |
|
2357
Amerant Bancorp
AMTB
$880M
| $887K | ﹤0.01% |
51,600
-3,100
| -6% | -$53.3K |
|
2358
AngioDynamics
ANGO
$445M
| $880K | ﹤0.01% |
84,400
| – | – |
|
2359
Vaalco Energy
EGY
$416M
| $880K | ﹤0.01% |
234,000
+11,800
| +5% | +$44.4K |
|
2360
Haverty Furniture Companies
HVT
$380M
| $879K | ﹤0.01% |
29,100
-1,400
| -5% | -$42.3K |
|
2361
Nurix Therapeutics
NRIX
$684M
| $878K | ﹤0.01% |
87,900
+11,600
| +15% | +$116K |
|
2362
Arcutis Biotherapeutics
ARQT
$2.11B
| $878K | ﹤0.01% |
92,100
| – | – |
|
2363
Artesian Resources
ARTNA
$342M
| $876K | ﹤0.01% |
18,550
| – | – |
|
|
VTNR
2364
DELISTED
Vertex Energy, Inc
VTNR
| $875K | ﹤0.01% |
140,000
+9,400
| +7% | +$58.8K |
|
2365
MaxCyte
MXCT
$151M
| $874K | ﹤0.01% |
190,400
+36,200
| +23% | +$166K |
|
2366
Coastal Financial
CCB
$1.69B
| $872K | ﹤0.01% |
23,165
-600
| -3% | -$22.6K |
|
2367
EVgo
EVGO
$515M
| $872K | ﹤0.01% |
218,000
+75,800
| +53% | +$303K |
|
2368
ATN International
ATNI
$235M
| $871K | ﹤0.01% |
23,800
| – | – |
|
2369
AnaptysBio
ANAB
$637M
| $866K | ﹤0.01% |
42,600
+5,700
| +15% | +$116K |
|
|
TRTX
2370
TPG RE Finance Trust
TRTX
$744M
| $866K | ﹤0.01% |
116,900
| – | – |
|
2371
Lyell Immunopharma
LYEL
$251M
| $864K | ﹤0.01% |
+13,585
| New | +$864K |
|
2372
W&T Offshore
WTI
$261M
| $864K | ﹤0.01% |
223,200
+6,900
| +3% | +$26.7K |
|
|
SBOW
2373
DELISTED
SilverBow Resources, Inc.
SBOW
| $859K | ﹤0.01% |
29,500
+600
| +2% | +$17.5K |
|
2374
GoodRx Holdings
GDRX
$1.43B
| $856K | ﹤0.01% |
155,100
+3,800
| +3% | +$21K |
|
2375
Aldeyra Therapeutics
ALDX
$333M
| $856K | ﹤0.01% |
+102,000
| New | +$856K |
|